Lexaria Bioscience Corp. (LEXX)
3.97
-0.08
(-1.98%)
USD |
NASDAQ |
Sep 11, 16:00
3.96
-0.01
(-0.25%)
After-Hours: 20:00
Lexaria Bioscience Shares Outstanding (Quarterly) : 1.652M for May 31, 2026
Shares Outstanding (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shares Outstanding (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 1.652M |
| February 28, 2026 | 1.659M |
| November 30, 2025 | 1.482M |
| August 31, 2025 | 1.304M |
| May 31, 2025 | 1.297M |
| February 28, 2025 | 1.163M |
| November 30, 2024 | 1.164M |
| August 31, 2024 | 1.054M |
| May 31, 2024 | 1.054M |
| February 29, 2024 | 0.8258M |
| November 30, 2023 | 0.6874M |
| May 31, 2023 | 0.5394M |
| February 28, 2023 | 0.3967M |
| November 30, 2022 | 0.3967M |
| August 31, 2022 | 0.3967M |
| May 31, 2022 | 0.3967M |
| February 28, 2022 | 0.3967M |
| November 30, 2021 | 0.3818M |
| August 31, 2021 | 0.3818M |
| May 31, 2021 | 0.3403M |
| February 28, 2021 | 0.3403M |
| November 30, 2020 | 0.2001M |
| August 31, 2020 | 0.2001M |
| May 31, 2020 | 0.1991M |
| February 29, 2020 | 0.1794M |
| Date | Value |
|---|---|
| November 30, 2019 | 0.1791M |
| August 31, 2019 | 0.1751M |
| May 31, 2019 | 0.1743M |
| February 28, 2019 | 0.1733M |
| November 30, 2018 | 0.1714M |
| August 31, 2018 | 0.1679M |
| May 31, 2018 | 0.1609M |
| February 28, 2018 | 0.158M |
| November 30, 2017 | 0.1543M |
| August 31, 2017 | 0.1511M |
| May 31, 2017 | 0.1479M |
| February 28, 2017 | 0.1251M |
| November 30, 2016 | 0.1222M |
| August 31, 2016 | 0.114M |
| May 31, 2016 | 0.1011M |
| February 29, 2016 | 0.099M |
| November 30, 2015 | 0.0977M |
| August 31, 2015 | 0.0974M |
| May 31, 2015 | 0.097M |
| February 28, 2015 | 0.0848M |
| November 30, 2014 | 0.0842M |
| July 31, 2014 | 0.0802M |
| April 30, 2014 | 0.0778M |
| January 31, 2014 | 0.0414M |
| October 31, 2013 | 0.0402M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shares Outstanding (Quarterly) Benchmarks
| Target Group, Inc. (Canada) | 617.03M |
| InMed Pharmaceuticals, Inc. | 5.339M |
| XORTX Therapeutics, Inc. | 1.731M |
| NervGen Pharma Corp. | 106.41M |
| Milestone Pharmaceuticals, Inc. | 124.50M |